Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Insulin Aspart (NovoLog)
Rapid-acting mealtime insulin analog.
Plain-Language Label Highlights
Brand names: NovoLog, Fiasp
Type 1 and type 2 diabetes — rapid mealtime coverage; Fiasp acts even faster.
A fast-acting insulin given at the start of meals to control after-meal blood sugar.
- •Hypoglycemia
- •Weight gain
- •Injection-site reactions
- •Lipodystrophy
- •Severe hypoglycemia
- •Hypokalemia
- •Hypersensitivity reactions
- •Hypoglycemia
- •Known aspart hypersensitivity
Educational summary of the FDA prescribing information. Not a substitute for the full label or medical advice. Always discuss with a licensed prescriber.
Mechanism of Action
Recombinant insulin analog with proline→aspartic acid at B28, reducing hexamer stability for rapid absorption and prandial glucose control.
Research Areas
Common Research Protocols
Subcutaneous dose within 5–10 minutes of starting a meal.
Protocols summarized for educational reference from published research. Not dosing guidance.
Cited Research
Aspart vs regular insulin postprandial control
Better postprandial glucose with similar overall safety.
Important Considerations
- •FDA-approved.
- •Hypoglycemia is the principal risk.
Explore more peptides
Educational Information Only — Not Medical Advice
All content on this page is for educational and informational purposes only. It is not medical advice, diagnosis, or treatment. We make no claims that any peptide can diagnose, treat, cure, or prevent any disease. Peptides discussed are not FDA-approved for the indications listed unless explicitly stated otherwise.
Always consult a licensed healthcare provider before beginning any wellness protocol. Statements have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability, eligibility, and pricing may vary.
Ask the Library
Ask anything about peptides — answers come from our curated reference library with citations.